Scarica l'app Stockscreener
4.39
0.46%
0.02
Dopo l'orario di chiusura:
4.31
-0.08
-1.82%
Precedente Chiudi:
$4.37
Aprire:
$4.39
Volume 24 ore:
525.11K
Relative Volume:
0.61
Capitalizzazione di mercato:
$543.82M
Reddito:
$69.56M
Utile/perdita netta:
$-240.05M
Rapporto P/E:
-1.4881
EPS:
-2.95
Flusso di cassa netto:
$-121.90M
1 W Prestazione:
+9.75%
1M Prestazione:
+7.33%
6M Prestazione:
+80.66%
1 anno Prestazione:
+116.26%
Intervallo 1D:
$4.21
$4.44
Intervallo di 1 settimana:
$3.9218
$4.44
Portata 52W:
$1.05
$4.80
Adc Therapeutics Sa Stock (ADCT) Company Profile
Nome
Adc Therapeutics Sa
Settore
Industria
Telefono
41 21 653 02 00
Indirizzo
BIOPOLE, EPALINGES
Confronta ADCT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ADCT
Adc Therapeutics Sa
|
4.39 | 541.34M | 69.56M | -240.05M | -121.90M | -2.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.82 | 107.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.32 | 80.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.80 | 57.37B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.93 | 55.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
209.02 | 44.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
Adc Therapeutics Sa Stock (ADCT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-08 | Iniziato | Stephens | Overweight |
| 2024-05-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-03-28 | Iniziato | Guggenheim | Buy |
| 2023-08-10 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2023-04-24 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-12-06 | Iniziato | CapitalOne | Overweight |
| 2022-11-09 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-09-21 | Iniziato | JP Morgan | Overweight |
| 2022-09-09 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-09 | Iniziato | Wolfe Research | Outperform |
| 2021-08-17 | Ripresa | Jefferies | Buy |
| 2021-08-09 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-06-15 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-12-03 | Iniziato | Stifel | Hold |
| 2020-10-29 | Iniziato | H.C. Wainwright | Buy |
| 2020-06-09 | Iniziato | BofA/Merrill | Buy |
| 2020-06-09 | Iniziato | Cowen | Outperform |
Mostra tutto
Adc Therapeutics Sa Borsa (ADCT) Ultime notizie
ADC Therapeutics SA (NYSE:ADCT) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
How ADC Therapeutics SA Common Shares stock expands through international markets2025 Momentum Check & Expert Curated Trade Setup Alerts - newser.com
How cyclical is ADC Therapeutics SA Common Shares stock compared to rivalsJuly 2025 Price Swings & Weekly Hot Stock Watchlists - newser.com
Can ADC Therapeutics SA stock attract ESG capital inflowsMarket Sentiment Report & Weekly Sector Rotation Insights - newser.com
Should I buy ADC Therapeutics SA Common Shares stock before earnings season2025 Major Catalysts & Weekly Chart Analysis and Trade Guides - newser.com
Chart overlay techniques for tracking ADC Therapeutics SAQuarterly Portfolio Review & High Accuracy Swing Trade Signals - newser.com
Will ADC Therapeutics SA Common Shares stock draw ESG focused fundsJuly 2025 Reactions & Daily Profit Focused Stock Screening - newser.com
Adc Therapeutics at Jefferies Conference: Strategic Expansion Plans By Investing.com - Investing.com UK
What indicators show strength in ADC Therapeutics SAJuly 2025 Snapshot & Consistent Income Trade Recommendations - newser.com
Will ADC Therapeutics SA Common Shares stock beat Nasdaq index returnsEarnings Risk Summary & Expert Curated Trade Ideas - newser.com
Is ADC Therapeutics SA stock a defensive play in 20252025 Retail Activity & Fast Gain Swing Trade Alerts - newser.com
ADC Therapeutics (ADCT) Upgraded to Buy: Here's What You Should Know - sharewise.com
Will ADC Therapeutics SA stock deliver long term returnsJuly 2025 Macro Moves & Free Reliable Trade Execution Plans - newser.com
ADC Therapeutics (ADCT) Secures PIPE Financing, Price Target Adjusted - MSN
Is ADC Therapeutics SA stock bottoming outJuly 2025 News Drivers & Reliable Breakout Stock Forecasts - newser.com
How to track smart money flows in ADC Therapeutics SAWeekly Stock Summary & High Accuracy Investment Entry Signals - newser.com
Wall Street Zen Upgrades ADC Therapeutics (NYSE:ADCT) to "Hold" - MarketBeat
Is it time to cut losses on ADC Therapeutics SACPI Data & Low Volatility Stock Recommendations - newser.com
Is ADC Therapeutics SA stock a top pick in earnings seasonQuarterly Profit Review & Community Driven Trade Alerts - newser.com
Why analysts upgrade ADC Therapeutics SA stockEarnings Overview Summary & Real-Time Market Sentiment Reports - newser.com
How institutional ownership impacts ADC Therapeutics SA stockTreasury Yields & Fast Gaining Stock Reports - newser.com
ADC Therapeutics SA Common Shares (NY: ADCT - Markets Financial Content
FY2025 EPS Estimates for ADCT Increased by Cantor Fitzgerald - MarketBeat
ADC Therapeutics S.A. (ADCT) Eyes Billion Dollar Opportunity with ZYNLATA Indication Expansion - MSN
[SCHEDULE 13G/A] ADC Therapeutics SA SEC Filing - Stock Titan
Momentum divergence signals in ADC Therapeutics SA chartTrade Performance Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Adc Therapeutics Sa Azioni (ADCT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.53%
1.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):